Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-07 Sale |
2023-02-17 4:46 pm |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cini John K. Chief Scientific Officer |
18,551 | $0 | $0 | 40,271 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-11 Option Award |
2024-12-05 9:55 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cini John K. Chief Scientific Officer |
1,888 | $0 | 2,116 (Direct) |
View |
| 2023-01-07 Option Award |
2023-02-17 4:46 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cini John K. Chief Scientific Officer |
18,551 | $0 | 40,271 (Direct) |
View |
| 2022-12-14 Option Award |
2022-12-22 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cini John K. Chief Scientific Officer |
18,551 | $0 | 322,652 (Direct) |
View |
| 2021-12-15 Option Award |
2022-04-08 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cini John K. Chief Scientific Officer |
80,034 | $0 | 304,101 (Direct) |
View |
| 2021-05-25 Tax Withholding |
2021-05-28 4:00 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cini John K. Chief Scientific Officer |
14,004 | $1.51 | 224,067 (Direct) |
View |
| 2020-07-02 Option Award |
2020-07-02 6:18 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cini John K. Chief Scientific Officer |
78,214 | $0 | 238,071 (Direct) |
View |